Biochemical and Biophysical Research Communications 1992-04-15

Peptide amidating enzymes are present in cultured endothelial cells.

C D Oldham, C Li, P R Girard, R M Nerem, S W May

Index: Biochem. Biophys. Res. Commun. 184(1) , 323-9, (1992)

Full Text: HTML

Abstract

Carboxy-terminal amidation is a prevalent post-translational modification necessary for the bioactivity of many peptides. We now report that the two enzymes essential for amidation, peptidylglycine alpha-monooxygenase (PAM) and peptidylamidoglycolate lyase (PGL), are present in both the cytosol and membrane fractions of cultured bovine aortic endothelial cells. Endothelial PAM exhibits ascorbate-dependent turnover and is inactivated by the mechanism-based inactivator, 4-phenyl-3-butenoic acid (PBA), whereas PGL activity is independent of ascorbate and is not affected by PBA. These enzymological characteristics correspond to those of amidating enzymes from other tissues. These results suggest a heretofore unrecognized role for alpha-amidated peptides in cardiovascular function.

Related Compounds

  • trans-Styrylacetic...

Related Articles:

Synthesis and antimalarial and antituberculosis activities of a series of natural and unnatural 4-methoxy-6-styryl-pyran-2-ones, dihydro analogues and photo-dimers.

2012-02-15

[Bioorg. Med. Chem. 20 , 1482-93, (2012)]

4-Phenyl-3-butenoic acid, an in vivo inhibitor of peptidylglycine hydroxylase (peptide amidating enzyme).

1990-04-30

[Eur. J. Biochem. 189(2) , 363-8, (1990)]

Selective mechanism-based inactivation of peptidylglycine alpha-hydroxylating monooxygenase in serum and heart atrium vs. brain.

1997-06-01

[Biochem. Pharmacol. 53(11) , 1695-702, (1997)]

Fragrance material review on 4-phenyl-3-buten-2-ol.

2012-09-01

[Food Chem. Toxicol. 50 Suppl 2 , S120-3, (2012)]

Probing the peptidylglycine alpha-hydroxylating monooxygenase active site with novel 4-phenyl-3-butenoic acid based inhibitors.

2010-09-03

[ChemMedChem 5(9) , 1568-76, (2010)]

More Articles...